Sibutramine alters the central mechanisms regulating the defended body weight in diet-induced obese rats

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 279, Issue 6 48-6, 2000, Pages

  Levin, B E ^a   Dunn Meynell, A A ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Arcuate nucleus; Epinephrine; Melanocortin; Neuropeptide Y; Norepinephrine; Proopiomelanocortin; Serotonin; Sympathetic nervous system

Indexed keywords

ADRENALIN; BRAIN MONOAMINE; LEPTIN; NEUROPEPTIDE Y; NORADRENALIN; PROOPIOMELANOCORTIN; SIBUTRAMINE;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ARCUATE NUCLEUS; ARTICLE; BODY FAT; BODY WEIGHT; CONTROLLED STUDY; DIET RESTRICTION; DRUG EFFECT; DRUG MECHANISM; ENERGY METABOLISM; FOOD INTAKE; MONOAMINE METABOLISM; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; URINE LEVEL; WEIGHT REDUCTION;

EID: 0033639182     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.2000.279.6.r2222     Document Type: Article

References (38)

1. Long-term maintenance of weight loss after a very-low-calorie diet: A randomized blinded trail of the efficacy and telerability of sibutramine
2. Effects of long-term treatment with antidepressant drugs on proopiomelanocortin and neuropeptide Y mRNA expression in the hypothalamic arcuate nucleus in rats
3. Altered expression of hypothalamic neuropeptide mRNAs in food-restricted and food-deprived rats
4. Sibutramine produces dose-related weight loss
5. Long term actions of D-fenfluramine in two rat models of obesity. I. Sustained reductions in body weight and adiposity without depletion of brain serotonin
6. Thermogenic effects of sibutramine and its metabolites
7. Effect of the antiobesity agent sibutramine in obese-diabetic ob/ob mice
8. Physical activity and low-fat diet: Is it enough to maintain weight stability in the reduced-obese individual following weight loss by drug therapy and energy restriction?
9. Increased feeding and neuropeptide Y (NPY) but not NPY mRNA levels in the hypothalamus of the rat following central administration of the serotonin synthesis inhibitor p-chlorophenylalanine
10. Effect of dexfenfluramine on body weight set-point: Study in the rat with hoarding behaviour
11. In vivo criteria to differentiate monoamine reuptake inhibitors from releasing agents: Sibutramine is a reuptake inhibitor
12. Efficacy and tolerability of sibutramine in obese patients: A dose-ranging study
13. Thermogenic effects of sibutramine in humans
14. Sibutramine: A novel anti-obesity drug. A review of the pharmacological evidence to differentiate it from D-amphetamine and D-fenfluramine
15. 2-adrenoceptors exclusively by sibutramine hydrochloride
16. Rat neuropeptide Y precursor gene expression
17. Investigation of the mechanisms underlying the hypophagic effects of the 5-HT and noradrenaline reuptake inhibitor, sibutramine, in the rat
18. Comparison of the effects of sibutramine and other monoamine reuptake inhibitors on food intake in the rat
19. Acute and long-term treatments with the selective serotonin reuptake inhibitor citalopram modulate the HPA axis activity at different levels in male rats
20. Chronic food restriction and acute food deprivation decrease mRNA levels of opioid peptides in arcuate nucleus
21. D-, L- and DL-fenfluramine cause long-lasting depletions of serotonin in rat brain
22. Sympathetic activity, age, sucrose preference and diet-induced obesity
23. Arcuate NPY neurons and energy homeostasis in diet-induced obese and resistant rats
24. Regulation of growth-associated protein 43 (GAP-43) messenger RNA associated with plastic change in the adult rat barrel receptor complex
25. Defense of body weight against chronic caloric restriction in obesity-prone and -resistant rats
26. Dysregulation of arcuate nucleus preproneuropeptide Y mRNA in diet-induced obese rats
27. Selective breeding for diet-induced obesity and resistance in Sprague-Dawley rats
28. Initiation and perpetuation of obesity and obesity resistance in rats
29. Defense of differing body weight set points in diet-induced obese and resistant rats
30. Tolerance to anorectic drugs: Pharmacological or artifactual
31. Effect on radiolabelled-monoamine uptake in vitro of plasma taken from healthy volunteers administered the antidepressant sibutramine HCl
32. The effect of fasting on neuropeptide Y mRNA and insulin receptors in the rat brain
33. Sibutramine reduces food intake in non-dieting women with obesity
34. Effects of sibutramine on resting metabolic rate and weight loss in overweight women
35. Effect of intracerebroventricular insulin infusion on diabetic hyperphagia and hypothalamic neuropeptide gene expression
36. D-Fenfluramine effects on hypothalamic activities and their hormonal correlates
37. Sibutramine and fat distribution: Is there a role for pharmacotherapy in abdominal/visceral fat reduction?
38. Increased hypothalamic content of preproneuropeptide-Y messenger ribonucleic acid in streptozotocin-diabetic rats